Antinuclear antibodies (ANA) were found in 20% of ankylosing spondylitis patients, often with low to moderate disease activity. This suggests ANA may be a potential biomarker in some ankylosing spondylitis cases.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: